Can Creatine Monohydrate Support Brain Fog and Cellular Energy in Long COVID and ME/CFS?

To understand how creatine monohydrate functions as a therapeutic tool, we must first understand its natural role in a healthy human body. Creatine is a nitrogenous organic acid, specifically an amino acid derivative, that is naturally synthesized in the liver, kidneys, and pancreas from three foundational amino acids: arginine, glycine, and methionine. Once produced, it is released into the bloodstream and actively transported into tissues with exceptionally high energy demands. While approximately 95% of the body's creatine is stored in skeletal muscle tissue, the remaining 5% is concentrated in highly metabolically active organs, most notably the brain, heart, and testes. In a standard diet, individuals consume small amounts of creatine through animal products like red meat and fish, though these dietary amounts are often insufficient to fully saturate the body's cellular storage capacity.

At the molecular level, creatine's primary function is to serve as an intracellular energy shuttle and a rapid-response energy buffer. It enters the cells via a specific transport protein known as the sodium-dependent creatine transporter (SLC6A8). Once inside the cellular fluid (cytoplasm), an enzyme called creatine kinase (CK) attaches a high-energy phosphate group to the creatine molecule, converting it into phosphocreatine (PCr). This phosphocreatine pool acts as a localized reservoir of potential energy, waiting in the wings for moments when the cell experiences sudden, intense metabolic stress and requires immediate fuel to function.

The true magic of creatine lies in its relationship with Adenosine Triphosphate (ATP), the universal "energy currency" of all living cells. Whenever a muscle fiber contracts to lift a heavy object, or a neuron fires to process a complex thought, the cell strips one phosphate group away from an ATP molecule. This breaking of the chemical bond releases the energy required to perform the work, leaving behind a depleted molecule called Adenosine Diphosphate (ADP). Because cells can only store a minuscule amount of ready-to-use ATP—enough to fuel perhaps two to five seconds of maximum exertion—this energy currency must be constantly and rapidly regenerated for the cell to survive and function.

This is exactly where the ATP-phosphocreatine system intervenes. During high-intensity exercise or acute metabolic stress, the mitochondria (the cell's power plants) often cannot produce new ATP fast enough through standard oxidative phosphorylation. In these critical moments, phosphocreatine steps in and rapidly donates its high-energy phosphate group back to the depleted ADP molecule. This instantaneous, anaerobic chemical reaction bypasses the slow mitochondrial machinery, instantly regenerating fresh ATP. It is the fastest energy-producing pathway in the human body, allowing cells to sustain maximum power output and maintain homeostasis even when their primary energy generators are overwhelmed.

While the ATP-phosphocreatine system is most famous for fueling short, explosive muscular efforts like sprinting or weightlifting, its role in brain bioenergetics is equally profound. The human brain is an extraordinarily energy-hungry organ; despite accounting for only about 2% of total body weight, it consumes roughly 20% of the body's resting energy. Every thought, memory retrieval, and sensory processing event requires a massive influx of ATP to maintain the electrical gradients across neuronal membranes. When the brain is subjected to metabolic stress—such as sleep deprivation, oxygen deprivation (hypoxia), or the systemic inflammation seen in chronic illness—its natural ATP stores are rapidly depleted.

In these neurological tissues, creatine acts as a crucial spatial and temporal energy buffer. Because ATP is a relatively large and cumbersome molecule, it diffuses slowly through the dense cellular cytoplasm from the mitochondria to the neuron synapses where the energy is actually needed. Creatine solves this logistical problem through the "creatine kinase shuttle." It takes the newly minted phosphate groups from the mitochondria, becomes the smaller and highly mobile phosphocreatine molecule, and rapidly diffuses across the cell to deliver the energy directly to the synapses. By ensuring a steady, rapid supply of ATP to the brain's most demanding regions, creatine helps safeguard cognitive function, may help prevent neuronal exhaustion, and supports the delicate bioenergetic balance required for clear, focused thought.

To comprehend why creatine is so relevant to complex chronic illnesses, we must examine the profound metabolic disruptions that characterize these conditions. For individuals living with Long COVID and ME/CFS, the most debilitating and defining symptom is post-exertional malaise (PEM). PEM is not simply ordinary fatigue; it is a severe, multi-systemic metabolic crash triggered by physical, cognitive, or emotional exertion that would have previously been easily tolerated. Research on post-exertional malaise demonstrates that patients with Long COVID experience PEM with onset and recovery times strikingly similar to those with ME/CFS, often suffering from worsening pain, neurologic deficits, and profound weakness after minimal activity.

At a cellular level, PEM represents an acute bioenergetic crisis. When a healthy person engages in activity, their mitochondria seamlessly ramp up ATP production to meet the demand. However, in patients with post-viral fatigue syndromes, this energy pipeline is fundamentally broken. When they attempt a task—whether it's walking up a flight of stairs or balancing a checkbook—their cells rapidly burn through whatever minimal ATP is available. Because their cellular machinery cannot regenerate ATP fast enough, the body hits a metabolic wall, triggering the cascading symptoms of a crash. If you are struggling to understand the boundaries of your energy envelope, you can learn more about how Early Overexertion Can Prolong and Worsen Long COVID Symptoms.

The root cause of this energy failure lies deep within the mitochondria. Viral infections, chronic inflammation, and immune dysregulation can inflict severe damage on the mitochondrial electron transport chain, specifically impairing Complex I function. Research from VU Amsterdam investigating skeletal muscle adaptations in Long COVID patients has revealed consistent impairments in mitochondrial respiration, alongside microvascular pathology such as capillary thickening and the presence of microclots. These vascular issues restrict the delivery of oxygen to the tissues, creating a state of localized cellular hypoxia.

Deprived of oxygen and burdened by faulty mitochondria, the cells are forced to abandon efficient aerobic energy production and rely instead on a primitive, inefficient backup system called anaerobic glycolysis. While glycolysis can produce ATP without oxygen, it does so very slowly and generates significant metabolic waste, most notably lactic acid. The rapid accumulation of lactic acid and hydrogen ions drops the pH within the muscle tissue, leading to the sensation of heavy, burning, leaden limbs and the profound muscular exhaustion that patients experience during a crash. This shift toward glycolytic metabolism traps the patient in a vicious cycle of energy debt and tissue distress.

This cellular energy crisis is not confined to the skeletal muscles; it heavily impacts the central nervous system, driving the severe cognitive dysfunction commonly referred to as "brain fog." A comprehensive review in Cell Reports Medicine highlights that shared biological abnormalities in Long COVID and ME/CFS—such as endothelial dysfunction and autoantibodies—trigger persistent neuroinflammation. This inflammation activates neural circuits responsible for "sickness behavior," forcing the brain into a torpor-like metabolic state to conserve energy. To understand the clinical manifestations of this neurological impact, you can read our detailed guide on What Is “Brain Fog” and Cognitive Dysfunction in Long COVID?.

Advanced brain imaging techniques, specifically Magnetic Resonance Spectroscopy (MRS), have provided visual proof of this neurological energy failure. Scans of ME/CFS and Long COVID patients consistently reveal significantly lower levels of ATP and altered phosphocreatine synthesis in highly demanding brain regions, such as the pregenual anterior cingulate cortex (pgACC) and the dorsolateral prefrontal cortex (DLPFC). The brain is literally starving for energy. When the neurons lack the ATP required to fire efficiently, the resulting deficits manifest as poor short-term memory, inability to find words, slowed processing speed, and overwhelming mental fatigue.

Given the profound mitochondrial dysfunction and ATP depletion seen in chronic complex illnesses, the therapeutic rationale for creatine supplementation becomes incredibly clear. By consuming exogenous creatine monohydrate, patients can significantly expand their intracellular pool of phosphocreatine. In skeletal muscle, consistent supplementation has been shown to increase phosphocreatine stores by approximately 20%, raising baseline levels from roughly 80 mmol/kg of dry muscle mass up to 100 mmol/kg. This expanded reservoir acts as a massive bioenergetic safety net for cells struggling to meet their daily energy quotas.

Crucially, the creatine kinase reaction—which donates the phosphate group to regenerate ATP—operates entirely independently of the damaged mitochondrial electron transport chain. It does not require oxygen, nor does it rely on the complex oxidative phosphorylation pathways that are often impaired by post-viral inflammation. By directly bypassing the faulty mitochondria, creatine provides an alternative, immediate source of cellular energy. This mechanism can effectively raise the threshold of physical and cognitive exertion a patient can tolerate before their cells run out of ATP, potentially delaying or mitigating the onset of the severe metabolic crashes characteristic of PEM.

Furthermore, the biochemical reaction that converts phosphocreatine into ATP actually consumes hydrogen ions in the process. This means that as creatine regenerates energy, it simultaneously acts as an intracellular buffer against acidity. By soaking up the excess hydrogen ions produced during anaerobic glycolysis, creatine helps delay the accumulation of lactic acid, thereby helping to reduce the painful, heavy, and burning sensations in the muscles that often accompany minimal physical exertion in ME/CFS and Long COVID patients.

While skeletal muscle readily absorbs creatine, transporting it into the brain requires crossing the highly selective blood-brain barrier. Fortunately, clinical research utilizing MRS imaging has confirmed that high-dose creatine supplementation successfully penetrates this barrier and significantly elevates cerebral creatine concentrations. By restoring these depleted pools in the brain's white matter and prefrontal cortex, creatine directly supports the high metabolic cost of cognitive function. When neurons have a readily available supply of phosphocreatine, they can maintain their electrical gradients and fire efficiently, even under the metabolic stress of neuroinflammation.

This restoration of brain bioenergetics is the primary mechanism behind creatine's potential to help lift "brain fog." A 2024 systematic review and meta-analysis involving nearly 500 participants demonstrated that creatine supplementation yields statistically significant improvements in memory and information processing speed, particularly in individuals whose brains are subjected to acute metabolic stressors like sleep deprivation or hypoxia. For patients with post-viral syndromes, providing the brain with this alternative fuel source can mean the difference between struggling to hold a conversation and regaining a measure of mental clarity.

Beyond its role as an energy shuttle, creatine exerts powerful neuroprotective and antioxidant effects that address the underlying pathophysiology of chronic illness. Chronic inflammation and mitochondrial dysfunction generate excessive amounts of reactive oxygen species (ROS)—unstable molecules that cause oxidative stress and damage cellular membranes, proteins, and DNA. Creatine has been shown to act as a direct antioxidant, scavenging these harmful free radicals and protecting delicate neural and muscular tissues from oxidative damage.

Additionally, creatine plays a vital role in stabilizing mitochondrial membranes and regulating intracellular calcium homeostasis. During a metabolic crisis, mitochondria can become overloaded with calcium, triggering the opening of the mitochondrial permeability transition pore (mPTP), which ultimately leads to cellular death (apoptosis). By maintaining ATP levels and supporting the function of calcium pumps, creatine may help prevent this catastrophic calcium overload, helping to preserve the structural integrity of the mitochondria and protect the cells from premature death. This multi-faceted mechanism makes creatine a highly targeted intervention for the complex bioenergetic failures seen in conditions like Long COVID and ME/CFS. If you are curious about the overlapping mechanisms of these conditions, explore our article on Can Long COVID Trigger ME/CFS? Unraveling the Connection.

Based on its mechanisms of action and emerging clinical data, creatine monohydrate may help manage several debilitating symptoms associated with complex chronic illnesses:

When considering supplementation, the form of creatine matters immensely. Creatine monohydrate is the undisputed gold standard, backed by decades of rigorous scientific research. Clinical pharmacokinetic studies establish that oral ingestion of creatine monohydrate is nearly 100% bioavailable in humans. Once consumed, it is rapidly absorbed into the bloodstream, causing a significant spike in blood plasma creatine levels—often reaching peak concentrations of approximately 287 µmol/L from a standard dose. From the blood, it is efficiently transported into skeletal muscle and brain tissues via the SLC6A8 transporter.

Despite aggressive marketing claims from companies selling alternative, more expensive forms of creatine (such as creatine ethyl ester or creatine hydrochloride), there is no clinical evidence that these variations offer superior absorption. Furthermore, a persistent myth suggests that creatine monohydrate is degraded into the waste product creatinine by stomach acid before it can be absorbed. Extensive clinical trials have thoroughly debunked this; creatine monohydrate is highly stable during normal human digestion. Thorne's Creatine Monohydrate utilizes a micronized form, which simply means the particles have been milled to a much smaller size. This significantly enhances its solubility, allowing it to dissolve completely in liquids and preventing the gritty texture that can cause mild stomach upset in some users.

There are two primary, evidence-based dosing protocols for achieving cellular creatine saturation. The first is the Loading Protocol, designed for rapid saturation. This involves taking 20 grams per day (divided into four 5-gram servings spread throughout the day) for 5 to 7 days. Following this loading phase, the dose is dropped to a maintenance level of 3 to 5 grams per day. This method achieves maximum muscle saturation and noticeable bioenergetic benefits in just about a week, which can be highly appealing for patients seeking rapid symptom relief.

The alternative is the Maintenance Protocol, which involves taking a steady dose of 3 to 5 grams per day from the very beginning. While it takes roughly 3 to 4 weeks (around 30 days) to achieve the exact same level of cellular saturation as the loading phase, this gradual approach is often preferred by patients with chronic illness. It is simpler to adhere to and significantly minimizes the risk of gastrointestinal discomfort or sudden water weight gain. Regardless of the protocol chosen, co-ingesting creatine with a carbohydrate source (like a small glass of juice) can stimulate a mild insulin release, which has been shown to enhance the transport and uptake of creatine into the muscle cells.

Creatine monohydrate boasts an unparalleled safety profile. A massive safety analysis of 685 human clinical trials involving over 12,800 participants confirmed that the prevalence of side effects in individuals taking creatine is virtually identical to those taking a placebo. In healthy individuals, continuous long-term use (even up to 10 grams daily for 5 years) does not lead to significant negative changes in kidney markers or liver function. However, because creatine is excreted by the kidneys, individuals with pre-existing renal disease should consult their healthcare provider before beginning supplementation.

When side effects do occur, they are generally mild and predictable. The most common is an initial weight gain of 1 to 3 pounds. It is crucial to understand that this is not fat gain; because creatine is a hygroscopic molecule, it draws water into the muscle cells, resulting in intracellular water retention. This actually improves cellular hydration and supports muscle health. Mild gastrointestinal issues, such as bloating or stomach cramps, can occur if a user consumes too much at once (e.g., a full 20g dose) or takes it on an empty stomach. Splitting doses, dissolving the powder completely in room-temperature water, and using a micronized form like Thorne's can effectively eliminate these issues. Furthermore, Thorne's product is NSF Certified for Sport®, ensuring absolute purity and the absence of contaminants—a critical factor for patients managing conditions like mast cell activation syndrome (MCAS) who have highly sensitive immune systems.

The application of creatine for post-viral fatigue is not merely theoretical; it is supported by a growing body of robust clinical trials. A 2023 clinical trial conducted by Slankamenac et al. evaluated the effects of 4 grams of dietary creatine monohydrate per day versus a placebo in patients suffering from post-COVID-19 fatigue syndrome over 6 months. The results were striking. By the 3-month mark, the creatine group experienced a significant reduction in general fatigue. At the 6-month follow-up, participants reported significant improvements in difficulties concentrating ("brain fog"), body aches, and breathing difficulties. Crucially, the researchers used Magnetic Resonance Spectroscopy (MRS) scans to prove that the supplementation significantly replenished depleted creatine levels in both the skeletal muscle and the white matter of the brain.

Building on this success, the same research team conducted an 8-week randomized controlled trial in 2024, this time co-administering 8 grams of creatine with 3 grams of glucose to enhance cellular uptake. The intervention yielded large, statistically significant effect sizes in reducing Long COVID symptoms. Specifically, the creatine-glucose group demonstrated an effect size of 0.80 for reducing difficulties concentrating and a massive 1.33 effect size for reducing body aches. The addition of glucose proved superior to creatine alone in elevating creatine levels across multiple brain locations, confirming the strategy of pairing the supplement with a small carbohydrate transport mechanism. Most recently, a 2025 clinical trial by Santos et al. demonstrated that just 4 weeks of 6g/day creatine supplementation significantly reduced fatigue scores and increased peripheral handgrip strength in Long COVID patients.

The evidence extending to ME/CFS is equally compelling, particularly regarding brain bioenergetics. A landmark 2024 brain imaging study by Godlewska et al. mapped exactly how creatine supplementation affects brain chemistry and clinical symptoms in ME/CFS patients. In this 6-week trial, 14 participants diagnosed with ME/CFS received a higher dose of 16 grams of creatine monohydrate per day. High-resolution 3 Tesla MRS brain scans taken before and after the trial revealed that the supplementation successfully penetrated the blood-brain barrier, increasing creatine concentrations by 8.3% in the pregenual anterior cingulate cortex (pgACC) and 2.9% in the dorsolateral prefrontal cortex.

This measurable restoration of brain energy correlated directly with tangible clinical improvements. The study documented clinically significant reductions in general fatigue among the participants. Furthermore, the patients experienced a highly significant increase in hand-grip strength—a standard marker of muscular endurance and nervous system output in ME/CFS—and demonstrated faster reaction times on cognitive assessments like the Stroop test. The researchers noted that higher increases of creatine in the brain directly correlated with these faster reaction times, providing a clear mechanistic link between cellular energy restoration and cognitive recovery.

Beyond specific post-viral syndromes, the broader scientific literature strongly supports creatine's role in cognitive enhancement and neuroprotection. The brain's reliance on the phosphocreatine system becomes glaringly apparent during times of metabolic stress. Studies consistently show that following 24 hours of sleep deprivation, taking creatine minimizes negative performance drops in choice reaction time, balance, and complex executive function. It acts as a bioenergetic safety net, helping to prevent the neuronal exhaustion that typically follows acute stress or oxygen deprivation.

Furthermore, individuals with naturally lower baseline creatine levels—such as vegetarians and vegans—show profound cognitive improvements upon supplementation. Because dietary creatine is predominantly found in animal products, plant-based eaters often operate with sub-optimal cellular saturation. When supplemented, these individuals experience significantly greater improvements in memory tasks compared to meat-eaters, highlighting the direct relationship between creatine availability and optimal brain function. For patients navigating the complex neurological landscape of chronic illness, these findings offer a validated, scientifically grounded pathway to supporting their cognitive health. To learn more about the diagnostic process for these complex conditions, read How Does a Doctor Diagnose Long COVID?.

Living with Long COVID, ME/CFS, or dysautonomia is an exercise in profound resilience. The daily reality of navigating unpredictable energy crashes, heavy limbs, and a thick mental fog can be incredibly isolating, especially when these invisible symptoms are not always understood by the broader medical community. It is essential to validate that your symptoms are not in your head; they are rooted in measurable, physiological disruptions to your body's fundamental cellular energy systems. The emerging research on mitochondrial dysfunction, lactic acid accumulation, and brain energy depletion provides a clear, biological explanation for the exhaustion you experience.

While there is currently no single magic pill or definitive cure for these complex post-viral syndromes, understanding the bioenergetic nature of your illness opens the door to targeted, scientifically grounded management strategies. Supplements like creatine monohydrate are not a cure-all, but they represent a powerful tool to help repair the broken energy pipeline. By providing an alternative source of rapid ATP regeneration, expanding your cellular energy reserves, and protecting delicate neural tissues from oxidative stress, creatine can help raise your baseline, reduce the severity of crashes, and improve your overall quality of life.

It is crucial to approach supplementation as one piece of a comprehensive, holistic management puzzle. Creatine works best when combined with meticulous pacing, strategic rest, and careful symptom tracking. Even as your cellular energy reserves begin to expand, it is vital not to immediately push your physical or cognitive boundaries, as doing so can trigger the very post-exertional malaise you are working to prevent. Listen to your body, respect your energy envelope, and allow the bioenergetic support to gradually stabilize your system. For more insights into the origins of these conditions, explore our article on What Causes Long COVID?.

Before adding any new supplement to your regimen, especially if you are managing complex chronic conditions, kidney issues, or taking multiple medications, always consult with your primary care physician or a specialist familiar with post-viral illnesses. They can help you determine the appropriate dosing protocol and ensure it aligns safely with your overall treatment plan. If you and your healthcare provider decide that supporting your cellular energy and cognitive function is the right next step, you can Explore Thorne Creatine to learn more about this rigorously tested, highly bioavailable option.